Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement

Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement Committee Meeting July 17, 2013, from 8 a.m. to 5 p.m. The committee will discuss the safety and efficacy for the new drug application (NDA) 203077, proposed trade name MOXDUO (morphine sulfate and oxycodone hydrochloride) capsules, submitted by QRxPharma Inc., for the proposed indication of management of moderate to severe acute pain where the use of an opioid analgesic is appropriate. This product represents the first drug combination consisting of two immediate-release opioids.